What is Catalog Technologies?
Catalog Technologies operates at the intersection of synthetic biology and high-performance computing. By developing a proprietary platform for automated DNA digital storage, the firm enables the encoding of massive datasets into synthetic DNA strands. This approach offers unprecedented density and longevity for archival data, addressing the critical storage bottlenecks faced by modern enterprise infrastructure. By integrating DNA synthesis and sequencing into a scalable algorithmic framework, Catalog Technologies is effectively redefining the physical limits of information retention.
How much funding has Catalog Technologies raised?
Catalog Technologies has raised a total of $50M across 3 funding rounds:
Angel/Seed
$5M
Series A
$10M
Series B
$35M
Angel/Seed (2017): $5M with participation from Wilson Sonsini, New Enterprise Associates, Industry Ventures, IndieBio, Kauffman Fellows, Pathbreaker Ventures, OS Fund, Starlight Ventures, SOSV, and StarVest Partners
Series A (2020): $10M led by Airbus Ventures and Horizons Ventures
Series B (2021): $35M supported by Hanwha Impact
Key Investors in Catalog Technologies
New Enterprise Associates
Established in 1977 and headquartered in Menlo Park, California, New Enterprise Associates is a venture capital firm focused on helping entrepreneurs build businesses.
Industry Ventures
Industry Ventures is a private equity and venture capital firm that specializes in providing flexible capital solutions across the full lifecycle of venture investing.
IndieBio
IndieBio is a pioneering biotech program that provides bio-labs and pre-seed investment to scientists aiming to launch startups in deep tech and synthetic biology.
What's next for Catalog Technologies?
With the successful completion of its latest funding round, Catalog Technologies is poised to accelerate the commercialization of its DNA storage platform. The strategic roadmap focuses on scaling production capabilities and refining the data encoding schemes required for seamless integration into existing enterprise workflows. As the company moves deeper into its growth phase, the focus will shift toward establishing partnerships with data-intensive industries, including cloud service providers and long-term archival institutions, to demonstrate the operational efficiency of its biological storage medium.
See full Catalog Technologies company page
